Approval · Notice of Compliance 1870 · 1999
CRIXIVAN: Notice of Compliance 1870
Issued March 16, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1870
- Date
- March 16, 1999
- Company
- Merck Frosst Canada Inc.Kirkland, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for a revised indication
- Therapeutic class
- Hiv protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CRIXIVAN | Not yet assigned | — |
Medicinal ingredients
- INDINAVIR SULFATE 100 MG per CAP
- INDINAVIR SULFATE 200 MG per CAP
- INDINAVIR SULFATE 300 MG per CAP
- INDINAVIR SULFATE 400 MG per CAP